BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

Antengene Announces HREC Approval in Australia

ATG-037 is the first orally-available, small molecule CD73 inhibitor to advance to clinical-stage by a Chinese company - The Phase I study will evaluate A...

February 07, 2022 | News

Cytiva fuels biotech development in Australia and New Zealand

Cytiva, a global life sciences leader, announces the winner of its first BioChallenge for the Australia and New Zealand region (ANZ). T...

February 01, 2022 | News

Australia approves Pfizer booster for 16–17 year olds

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people aged 16–17 years old. The adv...

January 31, 2022 | News

Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

January 20, 2022 | News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...

January 18, 2022 | News

How to Choose the Right At-Home COVID Test

Insight follows announcement that the Biden administration will purchase 500 million rapid COVID-19 tests and distribute free of cost to Americans With th...

December 22, 2021 | News

TCM provides new alternatives for the fight against COVID-19

Dr. Chen Zhen, President of the Central and Eastern European Federation of Chinese Medicine Societies, said that the Hungarian Qihuang TCM Center prov...

December 22, 2021 | News

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...

December 20, 2021 | News

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developin...

December 20, 2021 | News

Servatus to advance autoimmune therapies in Australia

Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders Funds raised will und...

December 09, 2021 | News

Effort to reduce burden of disease in Australia shines spotlight on natural medicine to support liver health

The prevalence of liver health issues is emerging as a serious cost and health burden for Australia with the spotlight on evidence-based natural ...

December 07, 2021 | Analysis

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE™ antiviral nasal spray in&nb...

December 06, 2021 | News

Clarity and Cardinal Health to address the growing needs in oncology

Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growin...

December 03, 2021 | News

World-first lung cancer screening facility increases chance of cure

The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...

December 01, 2021 | Influencers

Stay Connected